当前位置: X-MOL 学术Nat. Metab. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Author Correction: NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD.
Nature Metabolism ( IF 20.8 ) Pub Date : 2020-06-26 , DOI: 10.1038/s42255-020-0248-z
Michael Seimetz 1 , Natascha Sommer 1 , Mariola Bednorz 1 , Oleg Pak 1 , Christine Veith 1 , Stefan Hadzic 1 , Marija Gredic 1 , Nirmal Parajuli 1, 2 , Baktybek Kojonazarov 1, 3 , Simone Kraut 1 , Jochen Wilhelm 1, 3 , Fenja Knoepp 1 , Ingrid Henneke 1, 3 , Alexandra Pichl 1 , Zeki I Kanbagli 1 , Susan Scheibe 1 , Athanasios Fysikopoulos 1 , Cheng-Yu Wu 1 , Walter Klepetko 4 , Peter Jaksch 4 , Christina Eichstaedt 5, 6, 7 , Ekkehard Grünig 5, 7 , Katrin Hinderhofer 6 , Miklós Geiszt 8 , Niklas Müller 9 , Flavia Rezende 9 , Giulia Buchmann 9 , Ilka Wittig 10 , Matthias Hecker 1 , Andreas Hecker 11 , Winfried Padberg 11 , Peter Dorfmüller 12 , Stefan Gattenlöhner 12 , Claus F Vogelmeier 13 , Andreas Günther 1 , Srikanth Karnati 14, 15 , Eveline Baumgart-Vogt 14 , Ralph T Schermuly 1 , Hossein A Ghofrani 1, 16 , Werner Seeger 1, 17 , Katrin Schröder 9 , Friedrich Grimminger 1 , Ralf P Brandes 9 , Norbert Weissmann 1
Affiliation  

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

中文翻译:

作者更正:NADPH氧化酶亚基NOXO1是COPD肺气肿治疗的靶标。

该文件的修订版已经发布,可以通过文件顶部的链接进行访问。
更新日期:2020-06-26
down
wechat
bug